Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
(Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -25.74%15.95M | 156.79%48.73M | 169.70%4.09M | 190.72%7.2M | -32.25%15.97M | 131.52%21.48M | 216.55%18.98M | -64.36%-5.86M | -104.01%-7.93M | 1,763.40%23.57M |
Net income from continuing operations | 68.19%-5.12M | 2.80%-26.45M | 44.08%-6.71M | 35.49%-2.54M | 72.05%-1.11M | -120.05%-16.1M | -33.84%-27.22M | -77.39%-11.99M | 23.80%-3.94M | 4.40%-3.97M |
Operating gains losses | ---- | 2,122.22%600K | --0 | 265.38%129K | 62.60%200K | --271K | --27K | --23K | -809.09%-78K | 136.28%123K |
Depreciation and amortization | 16.26%379K | 23.76%1.4M | 24.83%372K | 29.24%358K | 19.72%340K | 21.19%326K | 238.74%1.13M | 175.93%298K | 218.39%277K | 110.37%284K |
Other non cash items | -215.50%-149K | 170.15%376K | 149.13%338K | -149.23%-162K | 1,283.33%71K | -29.51%129K | -420.96%-536K | -770.89%-688K | -332.14%-65K | -106.00%-6K |
Change In working capital | -70.96%8.13M | 208.56%19.9M | 63.08%-5.04M | 46.72%-6.01M | -86.08%2.93M | 169.82%28.01M | -33.04%6.45M | -25.84%-13.65M | -26,935.71%-11.27M | 301.31%21.07M |
-Change in receivables | -74.98%-5.46M | -60.72%-7.85M | 177.02%3M | 310.20%1.34M | -1,701.59%-9.06M | -2,223.13%-3.12M | -263.32%-4.88M | -409.16%-3.89M | -15.61%-637K | -481.06%-503K |
-Change in prepaid assets | -87.69%112K | 130.38%487K | 192.44%746K | -219.55%-850K | -4.25%-319K | 506.25%910K | -1,879.01%-1.6M | -418.97%-807K | -151.45%-266K | -305.37%-306K |
-Change in payables and accrued expense | -60.95%7.31M | 115.83%16.12M | -136.77%-14.6M | -130.77%-886K | 66.54%12.88M | 648.44%18.73M | 8.47%7.47M | 20.28%-6.17M | -37.25%2.88M | 17.91%7.73M |
-Change in other working capital | -46.31%6.17M | 103.79%11.14M | 309.08%5.82M | 57.67%-5.61M | -104.00%-566K | 44.46%11.49M | 31.10%5.47M | -7.16%-2.79M | -193.59%-13.25M | 989.56%14.14M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -25.74%15.95M | 156.79%48.73M | 169.70%4.09M | 190.72%7.2M | -32.25%15.97M | 131.52%21.48M | 216.55%18.98M | -63.94%-5.86M | -104.01%-7.93M | 1,763.48%23.57M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -462.45%-1.38M | 157.46%3.81M | 31.54%-178K | 124.41%545K | 248.19%3.69M | 62.07%-245K | 26.74%-6.63M | -134.44%-260K | 60.98%-2.23M | -166.52%-2.49M |
Net PPE purchase and sale | -196.88%-285K | -66.14%-1.05M | 55.25%-81K | -86.29%-367K | -355.45%-501K | 31.43%-96K | 55.33%-629K | 62.37%-181K | 34.77%-197K | 55.82%-110K |
Net investment purchase and sale | -633.56%-1.09M | 180.90%4.85M | -22.78%-97K | 144.79%912K | 276.11%4.19M | 70.55%-149K | -1,271.88%-6M | -104.07%-79K | 62.44%-2.04M | -159.61%-2.38M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -462.45%-1.38M | 157.46%3.81M | 31.54%-178K | 124.41%545K | 248.19%3.69M | 62.07%-245K | 26.74%-6.63M | -134.44%-260K | 60.98%-2.23M | -166.52%-2.49M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -62.53%-7.1M | -981.59%-33.14M | -325.44%-6.77M | -5,017.58%-13.97M | -1,108.89%-8.03M | -610.41%-4.37M | 60.96%-3.06M | -81.74%-1.59M | 77.98%-273K | 45.62%-664K |
Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net common stock issuance | -32.42%-6.12M | -1,166.42%-36.28M | -438.68%-5.95M | -4,217.14%-15.11M | -1,209.01%-10.6M | -669.22%-4.62M | 64.45%-2.87M | 3.92%-1.1M | 71.29%-350K | 31.36%-810K |
Proceeds from stock option exercised by employees | -49.43%310K | 1,150.00%6.28M | 831.11%658K | 424.74%1.99M | 1,961.64%3.01M | 828.79%613K | 89.43%502K | -146.88%-90K | 1,361.54%380K | 508.33%146K |
Net other financing activities | -259.05%-1.29M | -346.79%-3.13M | -272.86%-1.48M | -182.18%-855K | ---434K | ---359K | -3,589.47%-701K | -929.17%-398K | -1,162.50%-303K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -62.53%-7.1M | -981.59%-33.14M | -325.44%-6.77M | -5,017.58%-13.97M | -1,108.89%-8.03M | -610.41%-4.37M | 60.96%-3.06M | -81.74%-1.59M | 77.98%-273K | 45.62%-664K |
Net cash flow | ||||||||||
Beginning cash position | 71.63%47.47M | 50.90%27.66M | 41.85%50.13M | 20.74%56.44M | 68.54%44.51M | 50.90%27.66M | -37.08%18.33M | 61.05%35.34M | 42.64%46.75M | -8.89%26.41M |
Current changes in cash | -55.70%7.47M | 108.96%19.4M | 62.84%-2.87M | 45.54%-6.23M | -43.05%11.63M | 110.38%16.87M | 185.16%9.28M | -108.69%-7.71M | -5.43%-11.44M | 439.67%20.42M |
Effect of exchange rate changes | 422.22%29K | 831.82%410K | 600.00%203K | -348.48%-82K | 442.53%298K | -113.43%-9K | -56.00%44K | -63.75%29K | 50.00%33K | 65.48%-87K |
End cash Position | 23.48%54.97M | 71.63%47.47M | 71.63%47.47M | 41.85%50.13M | 20.74%56.44M | 68.54%44.51M | 50.90%27.66M | 50.90%27.66M | 61.05%35.34M | 43.74%46.75M |
Free cash flow | -26.74%15.67M | 159.90%47.69M | 166.27%4M | 184.01%6.83M | -34.07%15.47M | 134.01%21.38M | 300.00%18.35M | -48.96%-6.04M | -94.01%-8.13M | 2,209.35%23.46M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |